Published in Chest on November 01, 2000
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences. Lung (2007) 0.85
Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox. Haematologica (2010) 0.85
The relationship between FV Leiden and pulmonary embolism. Respir Res (2001) 0.84
Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr J Hematol Infect Dis (2011) 0.84
Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet (2007) 0.78
Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism. Yonsei Med J (2012) 0.77
Study of associated genetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism. Thrombosis (2014) 0.77
Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors? Chest (2000) 0.77
Inherited trombophilic states and pulmonary embolism. J Res Med Sci (2009) 0.75
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol (2010) 2.92
Effects of exposure to air pollution on blood coagulation. J Thromb Haemost (2006) 2.52
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø. J Thromb Haemost (2012) 2.01
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97
EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol (2006) 1.97
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol (2001) 1.60
Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients. Nephron (2000) 1.43
Arg506Gln factor V mutation and cerebral ischemia in the young. Stroke (1996) 1.42
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA (1999) 1.42
More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first-intended pregnancy: the matched case-control 'NOHA first' study. J Thromb Haemost (2006) 1.41
Frequency of factor V Arg506 Gln in Italians. Thromb Haemost (1996) 1.39
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost (2006) 1.37
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol (1999) 1.25
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
Risk of cerebral vein thrombosis and oral contraceptives. Lancet (1998) 1.18
Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med (1985) 1.15
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost (1997) 1.11
Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines. J Thromb Haemost (2013) 1.10
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol (2002) 1.08
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol (1997) 1.07
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost (1997) 1.05
Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica (2001) 1.03
Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia (2001) 1.02
Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost (2000) 1.02
The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol (2007) 1.02
Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet (2008) 1.01
Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril (2001) 1.01
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost (2003) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol (1998) 0.99
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest (1993) 0.99
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost (2009) 0.98
Oxidative stress and platelet activation in homozygous homocystinuria. Circulation (2001) 0.98
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest (1985) 0.97
Cost of care of haemophilia with inhibitors. Haemophilia (2009) 0.96
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost (1998) 0.96
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2012) 0.96
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res (2011) 0.95
Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol (1979) 0.94
Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost (2001) 0.94
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb (1994) 0.93
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost (1997) 0.93
Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy (2002) 0.92
The use of antithrombotic drugs in older people. Minerva Med (2002) 0.92
The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation. Br J Haematol (2001) 0.92
Diabetes, vascular complications and antiplatelet therapy: open problems. Acta Diabetol (2008) 0.91
Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood (1983) 0.90
Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele. Placenta (2010) 0.90
Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med (1986) 0.89
High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus (2010) 0.89
Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management. Haemophilia (2011) 0.89
Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? Br J Rheumatol (1996) 0.88
Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A. Haemophilia (2013) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost (2006) 0.87
Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol (1997) 0.87
Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol (1999) 0.87
Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol (1996) 0.86
Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). Nutr Metab Cardiovasc Dis (2003) 0.86
Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients. Thromb Haemost (1995) 0.85
Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias. J Thromb Haemost (2012) 0.85
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol (2003) 0.85
Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2004) 0.85
Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus (1995) 0.84